A Randomized, Open-Label Phase II Trial of Volasertib as Monotherapy and in Combination With Standard-Dose Pemetrexed Compared With Pemetrexed Monotherapy in Second-Line Treatment for Non–Small-Cell Lung Cancer

2015 ◽  
Vol 16 (6) ◽  
pp. 457-465 ◽  
Author(s):  
Peter M. Ellis ◽  
Natasha B. Leighl ◽  
Vera Hirsh ◽  
M. Neil Reaume ◽  
Normand Blais ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Standard Dose ◽  
Small Cell ◽  
Line Treatment ◽  
Second Line ◽  
Small Cell Lung ◽  
Open Label ◽  
Open Label Phase

Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial

2020 ◽  
Vol 21 (5) ◽  
pp. 645-654 ◽  
Author(s):  
José Trigo ◽  
Vivek Subbiah ◽  
Benjamin Besse ◽  
Victor Moreno ◽  
Rafael López ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Small Cell ◽  
Line Treatment ◽  
Second Line ◽  
Phase 2 ◽  
Small Cell Lung ◽  
Open Label ◽  
Open Label Phase ◽  
Basket Trial

Phase II trial of prolonged infusion gemcitabine as second line treatment in non-small cell lung cancer

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 7316-7316
Author(s):  
M. B. Kleinman ◽  
I. Stewart ◽  
S. Ratmanskiy ◽  
M. Gayle ◽  
P. Bonomi
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Line Treatment ◽  
Second Line ◽  
Small Cell Lung ◽  
Prolonged Infusion
Sign in / Sign up

Export Citation Format

Share Document